Cafepharma Today

October 24 2024 - Weight-loss drugs didn't curb health costs within two years
Weight-loss drugs didn't curb health costs within two years
GSK answers Pfizer's RSV approval with data targeting matching nod in younger adults
Why pharma megamergers may become a relic of the past
Lundbeck planning for four novel drugs in phase 3 in 2026
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Pfizer CEO Kindler Calls for More Science, Less Politics at FDA
WSJ Online
Friday, October 31, 2008 - 9:41am
tags:
Rigel's Punishment May Prove Short-Sighted
Seeking Alpha
Friday, October 31, 2008 - 9:39am
tags:
Reality Check on the Big Pharma Rumor Mill
Seeking Alpha
Friday, October 31, 2008 - 9:39am
tags:
Sanofi Increases Forecast as Profit Beats Estimates
Bloomberg
Friday, October 31, 2008 - 9:23am
tags:
Analysts see Allergan shares as long-term bet
Yahoo/AP
Friday, October 31, 2008 - 9:20am
tags:
Geron’s Q3 loss grows to $17.2M
Bizjournals.com
Friday, October 31, 2008 - 9:13am
tags:
Endo Pharmaceuticals Holdings increases 2008 profit outlook, reaffirms revenue guidance
Yahoo/AP
Friday, October 31, 2008 - 9:11am
tags:
Daiichi Sankyo Cuts Profit Forecast on Ranbaxy, R&D
Bloomberg
Friday, October 31, 2008 - 9:04am
tags:
Therapy plus Zoloft helps kids with anxiety
Yahoo/AP
Friday, October 31, 2008 - 9:02am
tags:
What's on Deck for AstraZeneca?
Motley Fool
Friday, October 31, 2008 - 9:00am
tags:
A Big Upgrade for Pfizer
Motley Fool
Friday, October 31, 2008 - 8:59am
tags:
Biogen to Pay Genentech in Cancer-Drug Collaboration
Bloomberg
Friday, October 31, 2008 - 8:57am
tags:
ImClone's Erbitux to Get Quicker Review by U.S. FDA
Bloomberg
Friday, October 31, 2008 - 8:48am
tags:
AstraZeneca Chooses Acquisitions Over Buybacks, Joining Glaxo
Bloomberg
Thursday, October 30, 2008 - 12:08pm
tags:
Mylan Profit Jumps 15% on Sale of Blood-Pressure Drug
Bloomberg
Thursday, October 30, 2008 - 12:06pm
tags:
Novo May Spend as Much as $2 Billion on Takeovers
Bloomberg
Thursday, October 30, 2008 - 12:06pm
tags:
Drug stocks rally in wake of Fed rate cut
Marketwatch
Thursday, October 30, 2008 - 12:05pm
tags:
A Strong Season for AstraZeneca’s Cholesterol Drug Crestor
WSJ Online
Thursday, October 30, 2008 - 12:03pm
tags:
Do Newly-Released FDA Memos Hurt Wyeth’s Preemption Argument?
WSJ Online
Thursday, October 30, 2008 - 11:27am
tags:
Glaxo's Avandia Should Be Banned, Public Citizen Says
Bloomberg
Thursday, October 30, 2008 - 11:14am
tags:

Pages

Latest CP Wire Articles

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Latest Pharmagather Articles

A Pfight at Pfizer
In the Pipeline
Clinical Trial Volunteers, And Others
In the Pipeline
The 340B Program Reached $66 Billion in 2023—Up 23% vs. 2022: Analyzing the Numbers and HRSA’s Curious Actions
Drug Channels
HCN in Acetonitrile, You Say?
In the Pipeline
Informa Connect’s Trade and Channel Strategies
Drug Channels
AI Does Not Make It Easy
In the Pipeline
The Promise of a Direct-to-Patient Model—Breaking Down What’s Really Needed for Better Patient Access
Drug Channels
Accelerated Approval: What Is It Accomplishing?
In the Pipeline
Cleaning up "Scientific Reports": Can It Be Done?
In the Pipeline

Latest Jobs

Account Manager-Orlando, FL-Ophthalmics
Maitland, Florida, 32794
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Alafaya, Florida
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Union Park, Florida
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Bunker Hill Village, Texas
Sun Pharmaceutical Industries, Inc.
Account Manager-Phoenix, AZ-Oncology
Paradise Valley, Arizona, 85253
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Pasadena, Texas, 77505
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Cloverleaf, Texas
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Gotha, Florida, 34734
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Longwood, Florida, 32791
Sun Pharmaceutical Industries, Inc.
Territory Manager - Medical Dermatology, Richmond VA
Richmond
Sun Pharmaceutical Industries, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information